one word that describes us

compassionate

 

Our Founder is a huge advocate of this healing process and our Doctor is a board certifed Addictionologist. We personally and professionally understand where each patient is coming from and support them 100%.

 

01. Medication-assisted treatment (MAT)

To combat this current health crisis, behavioral health organizations are increasingly utilizing evidence-based practices such as medication assisted treatment (MAT). Medications such as buprenorphine and prove effective in treating opioid use disorder.

02. Intensive outpatient treatment (IOP)

An intensive outpatient program (IOP) is a kind of treatment service and support program used primarily to treat eating disorders, bipolar disorder (including mania; and for types I and II), unipolar depression, self harm and chemical dependency that does not rely on detoxification.

03. Primary care & ketamine Infusion therapy

Primary care includes health promotion, disease prevention, health maintenance, counseling, patient education, diagnosis and treatment of acute and chronic illnesses. 

Ketamine was once used mainly as an anesthetic on battlefields and in operating rooms. Now this medication is gaining ground as a promising treatment for some cases of major depression.

 

 

 

 

50%-60% success rate nationally

Numbers Don’t Lie

In the first long-term follow-up of patients treated with buprenorphine/naloxone (Bp/Nx) for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy. After 3.5 years, the portion who reported being abstinent had risen further, to 61 percent, and fewer than 10 percent met diagnostic criteria for dependence on the drugs. (NIDA)

%

18 months

%

3.5 years

%

considered to be drug dependent

meet Our leaders

 Medical & Clinical

Dr. Sarah Merritt, MD

Medical Director Addictionologist

Dr. Latonya Niang, Ph.D

Clinical Director

Get In Touch

252 east high street, suite 1

+1 859-459-0796